RITUXIMAB-ABBS

RITUXIMAB-ABBS was reported 5105 times

RITUXIMAB-ABBS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEILECTOMY 2 0.6667
1 ADMINISTRATION SITE FIBROSIS 2 0.5000
2 AIRWAY PEAK PRESSURE DECREASED 2 0.4000
3 URETHROSCOPY 3 0.3000
4 GARDNERELLA TEST POSITIVE 7 0.2258
5 PERIPROSTHETIC METALLOSIS 3 0.1875
6 NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA 4 0.1290
7 NONINFECTIOUS MYELITIS 6 0.0732
8 WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0714
9 ANTIBIOTIC PROPHYLAXIS 3 0.0682
10 APNOEA TEST ABNORMAL 3 0.0625
11 COLD TYPE HAEMOLYTIC ANAEMIA 13 0.0553
12 ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY 2 0.0541
13 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0513
14 FACTOR XIII DEFICIENCY 3 0.0492
15 BLADDER ULCER 2 0.0488
16 CORYNEBACTERIUM TEST POSITIVE 3 0.0423
17 HAIRY CELL LEUKAEMIA 9 0.0386
18 CAPILLARY NAIL REFILL TEST ABNORMAL 4 0.0385
19 BENIGN PANCREATIC NEOPLASM 7 0.0368
20 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 2 0.0364
21 NEUTROPHIL COUNT 7 0.0333
22 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 10 0.0330
23 COLITIS EROSIVE 5 0.0314
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0286
25 ACQUIRED PORPHYRIA 2 0.0282
26 TACHYCARDIA INDUCED CARDIOMYOPATHY 3 0.0280
27 IMMUNE THROMBOCYTOPENIA 124 0.0271
28 MANTLE CELL LYMPHOMA 40 0.0263
29 NEPHRITIC SYNDROME 8 0.0258
30 HAEMOPHILUS TEST POSITIVE 3 0.0233
31 HAEMORRHAGIC EROSIVE GASTRITIS 7 0.0214
32 BACTERIAL PROSTATITIS 2 0.0202
33 SWOLLEN JOINT COUNT 5 0.0200
34 LIMB FRACTURE 3 0.0200
35 TREATMENT DELAYED 34 0.0196
36 PNEUMONIA CHLAMYDIAL 3 0.0191
37 FACET JOINT SYNDROME 62 0.0190
38 IMMUNOGLOBULIN G4 RELATED DISEASE 6 0.0188
39 MARGINAL ZONE LYMPHOMA 4 0.0187
40 DEEP VEIN THROMBOSIS POSTOPERATIVE 37 0.0185
41 GRIP STRENGTH 4 0.0175
42 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 4 0.0174
43 ENTEROVIRUS TEST POSITIVE 3 0.0172
44 NEUROMYELITIS OPTICA SPECTRUM DISORDER 23 0.0170
45 CHONDROCALCINOSIS 11 0.0168
46 RHEUMATIC FEVER 75 0.0168
47 VASOGENIC CEREBRAL OEDEMA 12 0.0167
48 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 118 0.0165
49 C-REACTIVE PROTEIN 15 0.0162
50 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 8 0.0159
51 ANTIBIOTIC THERAPY 15 0.0154
52 BLOOD IMMUNOGLOBULIN A DECREASED 10 0.0154
53 SYSTEMIC SCLERODERMA 11 0.0151
54 GRANULOCYTES ABNORMAL 3 0.0149
55 PERIPHERAL VENOUS DISEASE 61 0.0149
56 DISLOCATION OF VERTEBRA 34 0.0149
57 BLOOD IMMUNOGLOBULIN M INCREASED 9 0.0148
58 DUODENAL ULCER PERFORATION 110 0.0148
59 PYELITIS 3 0.0144
60 MONOCLONAL GAMMOPATHY 9 0.0144
61 CRYSTAL ARTHROPATHY 3 0.0143
62 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 8 0.0143
63 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 29 0.0140
64 SWOLLEN JOINT COUNT INCREASED 44 0.0138
65 HELICOBACTER INFECTION 140 0.0136
66 CARDIAC SARCOIDOSIS 3 0.0129
67 X-RAY ABNORMAL 23 0.0128
68 RETINITIS 22 0.0127
69 PORPHYRIA ACUTE 18 0.0125
70 RHEUMATOID FACTOR POSITIVE 71 0.0123
71 ACUTE HEPATITIS B 4 0.0120
72 CONGENITAL CYTOMEGALOVIRUS INFECTION 2 0.0118
73 THYROID CYST 7 0.0117
74 INFUSION RELATED HYPERSENSITIVITY REACTION 7 0.0116
75 C-REACTIVE PROTEIN ABNORMAL 74 0.0115
76 BIOPSY SKIN 2 0.0113
77 CRYOGLOBULINAEMIA 8 0.0112
78 ANTISYNTHETASE SYNDROME 2 0.0111
79 LUPUS VULGARIS 14 0.0111
80 LEUKOCYTURIA 9 0.0109
81 PEMPHIGUS 136 0.0109
82 VULVOVAGINAL INFLAMMATION 5 0.0108
83 ANTIPHOSPHOLIPID ANTIBODIES 2 0.0103
84 IMMUNODEFICIENCY COMMON VARIABLE 5 0.0102
85 SUSPECTED OFF LABEL USE 46 0.0102
86 POOR VENOUS ACCESS 105 0.0101
87 DEAFNESS CONGENITAL 2 0.0100
88 HAND DEFORMITY 130 0.0099
89 PRODUCT SUBSTITUTION 4 0.0099
90 ASPERGILLUS TEST POSITIVE 3 0.0097
91 AUTOIMMUNE HAEMOLYTIC ANAEMIA 33 0.0096
92 SERONEGATIVE ARTHRITIS 11 0.0096
93 ARTERITIS 6 0.0095
94 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 20 0.0091
95 VASCULAR DEVICE OCCLUSION 3 0.0088
96 BREAKTHROUGH COVID-19 2 0.0087
97 INTENTIONAL DOSE OMISSION 248 0.0087
98 DERMATOMYOSITIS 22 0.0087
99 HYPOCHOLESTEROLAEMIA 3 0.0085
100 DIVERTICULITIS INTESTINAL PERFORATED 3 0.0084
101 CYSTITIS ESCHERICHIA 3 0.0084
102 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 3 0.0082
103 FOLLICULITIS 85 0.0081
104 MUSCLE INJURY 67 0.0081
105 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
106 POLYMYOSITIS 14 0.0079
107 REACTIVE GASTROPATHY 3 0.0078
108 PERICARDITIS 129 0.0077
109 DUMPING SYNDROME 2 0.0076
110 ENCEPHALITIS AUTOIMMUNE 10 0.0076
111 SYNOVITIS 137 0.0076
112 BREAST CANCER STAGE III 49 0.0076
113 ONYCHOMYCOSIS 33 0.0075
114 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 5 0.0075
115 BLOOD IMMUNOGLOBULIN G INCREASED 9 0.0074
116 CENTRAL NERVOUS SYSTEM LYMPHOMA 10 0.0073
117 ONYCHOMADESIS 30 0.0071
118 INFECTION IN AN IMMUNOCOMPROMISED HOST 5 0.0070
119 SYSTOLIC HYPERTENSION 3 0.0069
120 GLOMERULONEPHRITIS MEMBRANOUS 8 0.0068
121 BONE EROSION 24 0.0068
122 MATERNAL EXPOSURE TIMING UNSPECIFIED 25 0.0066
123 HYPERCHOLESTEROLAEMIA 64 0.0066
124 EXPOSURE TO SARS-COV-2 11 0.0065
125 CONGENITAL ANOMALY 50 0.0065
126 BURSITIS 78 0.0064
127 FINGER DEFORMITY 31 0.0064
128 BLEPHAROSPASM 40 0.0063
129 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 41 0.0063
130 GLOSSODYNIA 140 0.0062
131 LIP DRY 54 0.0059
132 AUTOIMMUNE PANCREATITIS 3 0.0059
133 COLOSTOMY CLOSURE 2 0.0058
134 GRIP STRENGTH DECREASED 51 0.0058
135 SERUM SICKNESS 16 0.0057
136 PHARYNGEAL PARAESTHESIA 9 0.0057
137 HUMAN POLYOMAVIRUS INFECTION 3 0.0056
138 WHITE COAT HYPERTENSION 3 0.0055
139 INABILITY TO AFFORD MEDICATION 55 0.0055
140 GLOMERULONEPHRITIS MINIMAL LESION 4 0.0055
141 PULSE ABNORMAL 13 0.0054
142 ABSCESS RUPTURE 2 0.0053
143 GRANULOMATOSIS WITH POLYANGIITIS 6 0.0050
144 AUTOIMMUNE DISORDER 48 0.0049
145 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 7 0.0049
146 EAR PRURITUS 17 0.0048
147 PALATAL OEDEMA 6 0.0048
148 GIANT CELL ARTERITIS 4 0.0048
149 LIVE BIRTH 40 0.0048
150 JOINT RANGE OF MOTION DECREASED 64 0.0048
151 LARYNGEAL DISCOMFORT 3 0.0047
152 RHEUMATIC DISORDER 9 0.0047
153 CORONA VIRUS INFECTION 2 0.0047
154 SYSTEMIC LUPUS ERYTHEMATOSUS 165 0.0046
155 RELAPSING-REMITTING MULTIPLE SCLEROSIS 4 0.0046
156 OBLITERATIVE BRONCHIOLITIS 6 0.0046
157 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
158 OVERLAP SYNDROME 3 0.0043
159 LUPUS NEPHRITIS 8 0.0043
160 AUTOIMMUNE MYOSITIS 2 0.0042
161 NEPHROTIC SYNDROME 29 0.0042
162 CRANIAL NERVE PARALYSIS 2 0.0042
163 WOUND 118 0.0042
164 INSURANCE ISSUE 64 0.0042
165 PRODUCT LABEL CONFUSION 24 0.0041
166 WALKING AID USER 27 0.0041
167 DEVICE RELATED THROMBOSIS 4 0.0041
168 CONTRAINDICATED PRODUCT ADMINISTERED 120 0.0040
169 INTENTIONAL PRODUCT USE ISSUE 347 0.0040
170 WOUND INFECTION 43 0.0039
171 DRUG TOLERANCE DECREASED 11 0.0039
172 TRANSITIONAL CELL CARCINOMA 5 0.0039
173 INFUSION RELATED REACTION 251 0.0038
174 IRRITABLE BOWEL SYNDROME 79 0.0037
175 DIFFUSE LARGE B-CELL LYMPHOMA 28 0.0036
176 OBESITY 57 0.0036
177 BODY TINEA 2 0.0036
178 HEPATITIS A 3 0.0035
179 CONNECTIVE TISSUE DISORDER 5 0.0035
180 FOLATE DEFICIENCY 4 0.0035
181 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38 0.0034
182 POLYARTHRITIS 18 0.0034
183 TIBIA FRACTURE 16 0.0034
184 ADRENAL ADENOMA 2 0.0034
185 WHITE BLOOD CELL COUNT ABNORMAL 21 0.0033
186 CONTRAST MEDIA ALLERGY 6 0.0033
187 VASOSPASM 3 0.0033
188 LARYNGEAL OEDEMA 20 0.0032
189 ARTHRITIS REACTIVE 2 0.0032
190 NAIL DISORDER 28 0.0032
191 NASAL PRURITUS 4 0.0032
192 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 3 0.0032
193 HIP ARTHROPLASTY 48 0.0031
194 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
195 AORTIC VALVE DISEASE 5 0.0031
196 INFUSION SITE EXTRAVASATION 19 0.0030
197 FIBROMYALGIA 74 0.0030
198 SYMPTOM RECURRENCE 18 0.0030
199 ACQUIRED HAEMOPHILIA 3 0.0030
200 EXOSTOSIS 27 0.0030
201 COLITIS MICROSCOPIC 14 0.0030
202 INFUSION SITE DISCOMFORT 3 0.0029
203 DENTAL OPERATION 7 0.0028
204 MITRAL VALVE DISEASE 5 0.0028
205 FEBRILE BONE MARROW APLASIA 12 0.0028
206 INNER EAR DISORDER 3 0.0028
207 IMPAIRED HEALING 92 0.0028
208 PRESCRIBED OVERDOSE 54 0.0028
209 LUPUS-LIKE SYNDROME 25 0.0028
210 REFUSAL OF TREATMENT BY PATIENT 18 0.0028
211 COELIAC DISEASE 27 0.0027
212 THORACIC VERTEBRAL FRACTURE 8 0.0027
213 OFF LABEL USE 2347 0.0027
214 MIXED LIVER INJURY 8 0.0027
215 SCIATICA 42 0.0026
216 PUSTULAR PSORIASIS 9 0.0026
217 ADMINISTRATION SITE PAIN 3 0.0026
218 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
219 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
220 CATARACT OPERATION 15 0.0025
221 UNDERDOSE 180 0.0025
222 BALANOPOSTHITIS 2 0.0024
223 OXYGEN THERAPY 4 0.0024
224 POST-ACUTE COVID-19 SYNDROME 3 0.0024
225 DEVICE INFUSION ISSUE 6 0.0024
226 GASTRIC DILATATION 4 0.0024
227 VEIN RUPTURE 4 0.0024
228 TYPE 2 DIABETES MELLITUS 80 0.0024
229 JOINT DISLOCATION 25 0.0024
230 RHEUMATOID ARTHRITIS 264 0.0023
231 INFUSION SITE BRUISING 5 0.0023
232 VENTRICULAR DYSFUNCTION 6 0.0023
233 SINUS ARRHYTHMIA 3 0.0023
234 MENINGITIS CRYPTOCOCCAL 4 0.0023
235 NEUROLOGICAL SYMPTOM 13 0.0023
236 ARTHROPATHY 125 0.0022
237 PULMONARY FIBROSIS 43 0.0022
238 PSEUDOMEMBRANOUS COLITIS 5 0.0022
239 DRUG MONITORING PROCEDURE NOT PERFORMED 4 0.0022
240 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
241 SPONDYLITIS 8 0.0022
242 LOSS OF THERAPEUTIC RESPONSE 7 0.0022
243 OSTEOARTHRITIS 93 0.0022
244 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 5 0.0022
245 PSORIATIC ARTHROPATHY 88 0.0022
246 FOOT DEFORMITY 24 0.0022
247 TUMOUR LYSIS SYNDROME 19 0.0022
248 DEATH NEONATAL 3 0.0022
249 PHLEBITIS 11 0.0021
250 LIVER INJURY 52 0.0021
251 BACK INJURY 23 0.0021
252 HEPATIC ENZYME INCREASED 144 0.0021
253 AGRANULOCYTOSIS 39 0.0021
254 CEREBELLAR ATAXIA 2 0.0021
255 POST HERPETIC NEURALGIA 3 0.0021
256 HEPATIC CIRRHOSIS 39 0.0021
257 ILL-DEFINED DISORDER 125 0.0021
258 GLOMERULONEPHRITIS 5 0.0020
259 NORMOCYTIC ANAEMIA 3 0.0020
260 ADVERSE REACTION 27 0.0020
261 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
262 INFUSION SITE REACTION 6 0.0020
263 LYMPHOMA 31 0.0020
264 STEROID DIABETES 3 0.0020
265 KNEE ARTHROPLASTY 42 0.0020
266 THERAPY PARTIAL RESPONDER 31 0.0020
267 MYASTHENIA GRAVIS 16 0.0020
268 C-REACTIVE PROTEIN INCREASED 71 0.0019
269 LOWER RESPIRATORY TRACT INFECTION 88 0.0019
270 JOINT DESTRUCTION 3 0.0019
271 LOWER LIMB FRACTURE 37 0.0019
272 MEGACOLON 3 0.0019
273 HEPATITIS B REACTIVATION 6 0.0019
274 PRODUCT PRESCRIBING ISSUE 40 0.0018
275 NEUTROPENIC SEPSIS 13 0.0018
276 LIVER FUNCTION TEST INCREASED 39 0.0018
277 THROAT IRRITATION 81 0.0018
278 VACCINATION FAILURE 3 0.0018
279 HEPATIC ENZYME ABNORMAL 9 0.0018
280 NIGHT SWEATS 58 0.0018
281 HEPATORENAL SYNDROME 3 0.0018
282 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
283 ORAL PRURITUS 4 0.0017
284 VASCULITIS 20 0.0017
285 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
286 BREAST CANCER STAGE II 14 0.0017
287 HAEMOLYTIC ANAEMIA 15 0.0017
288 GASTROINTESTINAL OBSTRUCTION 4 0.0017
289 RASH VESICULAR 8 0.0017
290 PRESCRIBED UNDERDOSE 33 0.0017
291 PANNICULITIS 4 0.0017
292 GAIT INABILITY 55 0.0016
293 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
294 SOFT TISSUE INFECTION 3 0.0016
295 SUSPECTED PRODUCT QUALITY ISSUE 3 0.0016
296 PNEUMONIA KLEBSIELLA 3 0.0016
297 INFLAMMATION 84 0.0016
298 BLISTER 91 0.0016
299 BLOOD PRESSURE ABNORMAL 32 0.0016
300 AMPUTATION 2 0.0016
301 PREGNANCY 32 0.0016
302 HYPOPROTEINAEMIA 3 0.0016
303 TASTE DISORDER 32 0.0016
304 BLOOD CHOLESTEROL INCREASED 73 0.0016
305 HEPATITIS 40 0.0016
306 THERAPEUTIC PRODUCT EFFECT DECREASED 70 0.0016
307 MYOSITIS 14 0.0016
308 CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0015
309 HYPOGAMMAGLOBULINAEMIA 10 0.0015
310 DISCOMFORT 92 0.0015
311 POLYNEUROPATHY 18 0.0015
312 LARYNGOSPASM 4 0.0015
313 THROAT TIGHTNESS 40 0.0015
314 NORMAL NEWBORN 8 0.0015
315 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
316 LUNG DISORDER 72 0.0015
317 IMPULSE-CONTROL DISORDER 3 0.0015
318 LEG AMPUTATION 6 0.0015
319 OROPHARYNGEAL DISCOMFORT 13 0.0014
320 DRUG-INDUCED LIVER INJURY 45 0.0014
321 MOBILITY DECREASED 103 0.0014
322 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
323 EAR SWELLING 3 0.0014
324 TREATMENT FAILURE 117 0.0014
325 GENERALISED ERYTHEMA 8 0.0014
326 STOMATITIS 85 0.0014
327 PNEUMOCYSTIS JIROVECII PNEUMONIA 14 0.0014
328 ANAPHYLACTIC REACTION 77 0.0014
329 HYPERTENSION 295 0.0014
330 ATRIAL FLUTTER 11 0.0014
331 CUTANEOUS VASCULITIS 5 0.0014
332 THROMBOCYTOSIS 5 0.0014
333 COLONOSCOPY 3 0.0014
334 COVID-19 PNEUMONIA 16 0.0014
335 ANKLE OPERATION 2 0.0014
336 DRUG INTOLERANCE 130 0.0013
337 TONSILLITIS 7 0.0013
338 EPILEPSY 41 0.0013
339 CHEMOTHERAPY 5 0.0013
340 EYE INJURY 4 0.0013
341 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
342 MULTIPLE ALLERGIES 10 0.0013
343 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
344 JOINT SWELLING 153 0.0013
345 URINARY HESITATION 3 0.0013
346 IMMUNOSUPPRESSION 11 0.0012
347 DIABETES INSIPIDUS 3 0.0012
348 ACUTE LEUKAEMIA 2 0.0012
349 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 36 0.0012
350 BRONCHITIS CHRONIC 3 0.0012
351 IMMUNE SYSTEM DISORDER 16 0.0012
352 SUSPECTED COVID-19 4 0.0012
353 SARS-COV-2 TEST POSITIVE 16 0.0012
354 DELIRIUM 42 0.0012
355 IMMUNODEFICIENCY 18 0.0012
356 NEPHRITIS 4 0.0012
357 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
358 SENSATION OF FOREIGN BODY 10 0.0012
359 ULCER HAEMORRHAGE 8 0.0012
360 HYPERPYREXIA 5 0.0012
361 MATERNAL EXPOSURE DURING PREGNANCY 105 0.0012
362 B-CELL LYMPHOMA 4 0.0012
363 SWELLING 110 0.0012
364 MUSCULOSKELETAL PAIN 61 0.0012
365 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
366 WEIGHT FLUCTUATION 12 0.0011
367 OXYGEN SATURATION DECREASED 64 0.0011
368 GASTROINTESTINAL DISORDER 102 0.0011
369 MUSCULOSKELETAL STIFFNESS 99 0.0011
370 CHOLANGITIS 7 0.0011
371 WHEELCHAIR USER 5 0.0011
372 SHOULDER ARTHROPLASTY 3 0.0011
373 OEDEMA 60 0.0011
374 SCLERODERMA 4 0.0011
375 HEPATIC CYTOLYSIS 14 0.0011
376 WHEEZING 65 0.0011
377 RHEUMATOID NODULE 3 0.0011
378 INTERCEPTED MEDICATION ERROR 5 0.0011
379 ADENOCARCINOMA OF COLON 2 0.0011
380 JOINT STIFFNESS 28 0.0011
381 GENERAL SYMPTOM 8 0.0011
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51 0.0011
383 NEUTROPHIL COUNT ABNORMAL 3 0.0011
384 HYPERSENSITIVITY 197 0.0011
385 JOINT LOCK 3 0.0011
386 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
387 INJURY 74 0.0011
388 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
389 ANURIA 9 0.0010
390 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
391 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
392 PHARYNGEAL SWELLING 10 0.0010
393 BICYTOPENIA 2 0.0010
394 EAR INFECTION 27 0.0010
395 RESPIRATORY RATE INCREASED 9 0.0010
396 NEUTROPHIL COUNT DECREASED 41 0.0010
397 THERAPY NON-RESPONDER 45 0.0010
398 SKIN REACTION 14 0.0010
399 PLATELET COUNT ABNORMAL 6 0.0010
400 DRUG TOLERANCE 5 0.0010
401 TOXIC ENCEPHALOPATHY 5 0.0010
402 DRY THROAT 10 0.0010
403 FEBRILE NEUTROPENIA 65 0.0010
404 DEMYELINATION 4 0.0010
405 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8 0.0010
406 CAPILLARY LEAK SYNDROME 2 0.0010
407 INFUSION SITE SWELLING 6 0.0010
408 ENTERITIS 6 0.0009
409 LOOSE TOOTH 3 0.0009
410 DEREALISATION 2 0.0009
411 CHILLS 108 0.0009
412 PNEUMONITIS 25 0.0009
413 IMMOBILE 4 0.0009
414 INFUSION SITE HAEMORRHAGE 3 0.0009
415 DIABETIC NEPHROPATHY 2 0.0009
416 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
417 ANXIETY DISORDER 3 0.0009
418 CORNEAL OEDEMA 2 0.0009
419 ACUTE PULMONARY OEDEMA 5 0.0009
420 HEAVY MENSTRUAL BLEEDING 8 0.0009
421 POSTOPERATIVE WOUND INFECTION 6 0.0009
422 LIVER DISORDER 39 0.0009
423 NECK PAIN 49 0.0009
424 THERAPY INTERRUPTED 62 0.0009
425 ENCEPHALITIS 6 0.0009
426 LOCALISED OEDEMA 4 0.0009
427 AUTOIMMUNE HEPATITIS 6 0.0009
428 ABDOMINAL DISCOMFORT 143 0.0009
429 ESCHERICHIA INFECTION 7 0.0009
430 DRY MOUTH 69 0.0008
431 BACTERAEMIA 10 0.0008
432 EXPOSURE DURING PREGNANCY 52 0.0008
433 CONTUSION 80 0.0008
434 FACE OEDEMA 14 0.0008
435 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
436 GUILLAIN-BARRE SYNDROME 4 0.0008
437 SINUSITIS 84 0.0008
438 THERAPY CESSATION 42 0.0008
439 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
440 MULTIPLE SCLEROSIS 39 0.0008
441 ANAPHYLACTIC SHOCK 21 0.0008
442 THERAPY CHANGE 8 0.0008
443 MENISCUS INJURY 5 0.0008
444 RASH MACULO-PAPULAR 18 0.0008
445 HYPERTENSIVE CRISIS 9 0.0008
446 ORGANISING PNEUMONIA 4 0.0008
447 INFLAMMATORY MARKER INCREASED 4 0.0008
448 THROAT CLEARING 3 0.0008
449 FLUID INTAKE REDUCED 4 0.0008
450 DERMATITIS EXFOLIATIVE 4 0.0008
451 CORONARY ARTERY STENOSIS 4 0.0008
452 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
453 SLEEP DISORDER 56 0.0008
454 TONGUE OEDEMA 3 0.0008
455 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
456 GASTROINTESTINAL INFECTION 7 0.0008
457 INFUSION SITE PAIN 10 0.0008
458 BRONCHOSPASM 11 0.0008
459 OPTIC NEURITIS 7 0.0008
460 HYPOXIA 27 0.0008
461 PRODUCT USE ISSUE 144 0.0008
462 PROSTATOMEGALY 3 0.0008
463 PRODUCT PREPARATION ISSUE 5 0.0008
464 INCONTINENCE 8 0.0008
465 SUDDEN DEATH 8 0.0008
466 SKIN PAPILLOMA 3 0.0007
467 ALOPECIA 146 0.0007
468 EOSINOPHILIA 13 0.0007
469 WRONG PRODUCT ADMINISTERED 5 0.0007
470 SPINAL FUSION SURGERY 3 0.0007
471 NEUTROPENIA 100 0.0007
472 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
473 ARTHRITIS BACTERIAL 3 0.0007
474 FAECALOMA 4 0.0007
475 DEAFNESS UNILATERAL 4 0.0007
476 EAR PAIN 14 0.0007
477 URTICARIA 120 0.0007
478 BRONCHITIS 53 0.0007
479 MACULAR OEDEMA 4 0.0007
480 LYMPHOPENIA 10 0.0007
481 COVID-19 124 0.0007
482 CEREBRAL THROMBOSIS 2 0.0007
483 BASAL CELL CARCINOMA 11 0.0007
484 CARDIAC FAILURE CHRONIC 3 0.0007
485 INTERSTITIAL LUNG DISEASE 34 0.0007
486 CARDIAC VALVE DISEASE 4 0.0007
487 LEUKOPENIA 35 0.0007
488 PYREXIA 242 0.0007
489 EMPHYSEMA 7 0.0007
490 ROAD TRAFFIC ACCIDENT 29 0.0007
491 DYSPNOEA AT REST 2 0.0007
492 SKIN WARM 4 0.0007
493 SPINAL OSTEOARTHRITIS 6 0.0007
494 HYPOAESTHESIA 102 0.0007
495 LUNG INFILTRATION 6 0.0007
496 ABDOMINAL ABSCESS 3 0.0007
497 GLAUCOMA 13 0.0007
498 ARTHRITIS 53 0.0007
499 HERNIA 13 0.0007
500 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
501 ODYNOPHAGIA 4 0.0007
502 RESPIRATORY DISORDER 20 0.0007
503 OEDEMA PERIPHERAL 81 0.0007
504 PEMPHIGOID 5 0.0007
505 NASOPHARYNGITIS 122 0.0007
506 CYSTITIS 21 0.0007
507 SKIN ULCER 17 0.0007
508 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
509 LYMPHADENOPATHY 23 0.0006
510 SYNOVIAL CYST 3 0.0006
511 COLITIS ULCERATIVE 29 0.0006
512 UNEVALUABLE EVENT 49 0.0006
513 PRODUCT DISTRIBUTION ISSUE 6 0.0006
514 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
515 CONFUSIONAL STATE 104 0.0006
516 TOOTH EXTRACTION 8 0.0006
517 PERIPHERAL SWELLING 99 0.0006
518 VAGINAL INFECTION 3 0.0006
519 HEPATOCELLULAR INJURY 9 0.0006
520 SARCOIDOSIS 3 0.0006
521 MIGRAINE 60 0.0006
522 CONDITION AGGRAVATED 188 0.0006
523 HIATUS HERNIA 8 0.0006
524 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
525 PRODUCT AVAILABILITY ISSUE 14 0.0006
526 POLYURIA 5 0.0006
527 ASTHMA 69 0.0006
528 PANCYTOPENIA 34 0.0006
529 OSTEOPOROSIS 25 0.0006
530 DISABILITY 12 0.0006
531 PULMONARY MASS 9 0.0006
532 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
533 FEELING HOT 37 0.0006
534 KLEBSIELLA INFECTION 3 0.0006
535 FREQUENT BOWEL MOVEMENTS 16 0.0006
536 HERPES ZOSTER 34 0.0006
537 CLOSTRIDIAL INFECTION 2 0.0006
538 THROMBOCYTOPENIA 66 0.0006
539 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
540 INFECTION 85 0.0006
541 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
542 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
543 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
544 CHEST DISCOMFORT 59 0.0006
545 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
546 HYPERTRANSAMINASAEMIA 4 0.0006
547 PARAESTHESIA 90 0.0006
548 BLOOD PRESSURE INCREASED 87 0.0006
549 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
550 HAND FRACTURE 4 0.0006
551 RHINORRHOEA 36 0.0006
552 BACK DISORDER 9 0.0006
553 PRODUCT USE IN UNAPPROVED INDICATION 137 0.0006
554 RASH PUSTULAR 4 0.0005
555 MULTIPLE FRACTURES 9 0.0005
556 HYPERKERATOSIS 3 0.0005
557 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
558 CARDIOMYOPATHY 8 0.0005
559 INTRACRANIAL PRESSURE INCREASED 3 0.0005
560 PNEUMONIA 174 0.0005
561 RASH 234 0.0005
562 OVERDOSE 115 0.0005
563 DISEASE PROGRESSION 63 0.0005
564 COLECTOMY 3 0.0005
565 MOUTH SWELLING 3 0.0005
566 ELECTROLYTE IMBALANCE 6 0.0005
567 APHTHOUS ULCER 4 0.0005
568 POST PROCEDURAL HAEMORRHAGE 6 0.0005
569 CARDIOPULMONARY FAILURE 2 0.0005
570 THERAPEUTIC RESPONSE SHORTENED 17 0.0005
571 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
572 BRAIN FOG 8 0.0005
573 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
574 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
575 DIVERTICULITIS 14 0.0005
576 BLOOD PRESSURE FLUCTUATION 12 0.0005
577 CYTOKINE RELEASE SYNDROME 10 0.0005
578 DYSPEPSIA 49 0.0005
579 PRURITUS 191 0.0005
580 MUCOSAL INFLAMMATION 13 0.0005
581 PRESYNCOPE 12 0.0005
582 FOETAL GROWTH RESTRICTION 3 0.0005
583 DIALYSIS 7 0.0005
584 ARTHRALGIA 204 0.0005
585 HICCUPS 4 0.0005
586 ANAPHYLACTOID REACTION 2 0.0005
587 OLIGURIA 3 0.0005
588 EMBOLISM 4 0.0005
589 ADVERSE DRUG REACTION 43 0.0005
590 AMNESIA 31 0.0005
591 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
592 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
593 FEELING COLD 13 0.0005
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
595 ILLNESS 48 0.0005
596 INJECTION SITE REACTION 32 0.0005
597 POOR QUALITY SLEEP 10 0.0005
598 OROPHARYNGEAL PAIN 43 0.0005
599 CARDIAC FLUTTER 3 0.0005
600 MYOPATHY 4 0.0005
601 HOSPITALISATION 71 0.0005
602 DEEP VEIN THROMBOSIS 30 0.0005
603 CHAPPED LIPS 2 0.0005
604 SEPTIC SHOCK 20 0.0005
605 DIVERTICULUM INTESTINAL 2 0.0005
606 WEIGHT INCREASED 102 0.0005
607 THYROID DISORDER 7 0.0005
608 CHEST PAIN 84 0.0005
609 PURPURA 4 0.0005
610 DYSPNOEA EXERTIONAL 17 0.0005
611 EJECTION FRACTION DECREASED 7 0.0004
612 TRANSAMINASES INCREASED 10 0.0004
613 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
614 SKIN MASS 3 0.0004
615 HYPOTENSION 90 0.0004
616 PAIN IN EXTREMITY 132 0.0004
617 DECREASED APPETITE 104 0.0004
618 PRODUCT ADMINISTRATION ERROR 9 0.0004
619 BRONCHIECTASIS 3 0.0004
620 PAIN 272 0.0004
621 RECTAL HAEMORRHAGE 19 0.0004
622 PRODUCT LABEL ISSUE 3 0.0004
623 DISEASE RECURRENCE 21 0.0004
624 TACHYPNOEA 6 0.0004
625 BODY TEMPERATURE INCREASED 9 0.0004
626 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
627 RESTLESS LEGS SYNDROME 8 0.0004
628 TACHYCARDIA 39 0.0004
629 DYSPNOEA 246 0.0004
630 NERVE COMPRESSION 4 0.0004
631 DISORIENTATION 17 0.0004
632 SURGERY 25 0.0004
633 ARTERIOSCLEROSIS 4 0.0004
634 SQUAMOUS CELL CARCINOMA 4 0.0004
635 CYTOMEGALOVIRUS INFECTION 7 0.0004
636 CATARACT 25 0.0004
637 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
638 CHOLESTASIS 8 0.0004
639 MEDICATION ERROR 23 0.0004
640 FLUSHING 42 0.0004
641 MALAISE 179 0.0004
642 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
643 ASTHENIA 153 0.0004
644 KNEE OPERATION 4 0.0004
645 HYPOPHOSPHATAEMIA 3 0.0004
646 TENDON RUPTURE 5 0.0004
647 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
648 URINARY TRACT INFECTION 68 0.0004
649 TOXIC SKIN ERUPTION 4 0.0004
650 EYE DISORDER 13 0.0004
651 HYPOTHERMIA 4 0.0004
652 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
653 EAR DISCOMFORT 4 0.0004
654 CACHEXIA 2 0.0004
655 ABDOMINAL PAIN UPPER 80 0.0004
656 ATRIOVENTRICULAR BLOCK 3 0.0004
657 LIMB DISCOMFORT 12 0.0004
658 ANKLE FRACTURE 6 0.0004
659 MUSCULAR WEAKNESS 44 0.0004
660 MEMORY IMPAIRMENT 53 0.0004
661 PETECHIAE 4 0.0004
662 CYANOSIS 6 0.0004
663 MUSCLE SPASMS 70 0.0004
664 MOUTH ULCERATION 8 0.0004
665 PULMONARY CONGESTION 5 0.0004
666 ACUTE KIDNEY INJURY 58 0.0004
667 LOW BIRTH WEIGHT BABY 3 0.0004
668 GINGIVAL PAIN 3 0.0004
669 EYE HAEMORRHAGE 5 0.0004
670 STENT PLACEMENT 3 0.0004
671 CHEILITIS 2 0.0004
672 UVEITIS 5 0.0004
673 PROTEINURIA 7 0.0004
674 PALLOR 10 0.0004
675 ACUTE HEPATIC FAILURE 5 0.0004
676 PERIPHERAL COLDNESS 5 0.0004
677 GASTROINTESTINAL PAIN 4 0.0004
678 CELLULITIS 18 0.0004
679 SKIN INFECTION 4 0.0004
680 OCULAR DISCOMFORT 4 0.0004
681 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
682 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
683 VITAMIN D DECREASED 3 0.0004
684 DRUG RESISTANCE 9 0.0004
685 PULMONARY EMBOLISM 33 0.0003
686 COUGH 97 0.0003
687 ERYTHEMA 71 0.0003
688 HEADACHE 216 0.0003
689 HEART RATE DECREASED 12 0.0003
690 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
691 COLD SWEAT 6 0.0003
692 RIB FRACTURE 7 0.0003
693 PRODUCT COMMUNICATION ISSUE 3 0.0003
694 FATIGUE 261 0.0003
695 PRODUCTIVE COUGH 16 0.0003
696 WRIST FRACTURE 4 0.0003
697 ANAL INCONTINENCE 3 0.0003
698 LOCALISED INFECTION 8 0.0003
699 ANAEMIA 63 0.0003
700 NEPHROLITHIASIS 15 0.0003
701 MUSCLE SPASTICITY 4 0.0003
702 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
703 UROSEPSIS 3 0.0003
704 INTERCEPTED PRODUCT PREPARATION ERROR 4 0.0003
705 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
706 BRADYCARDIA 17 0.0003
707 SECRETION DISCHARGE 4 0.0003
708 BLOOD PRESSURE DECREASED 21 0.0003
709 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
710 RESPIRATORY TRACT CONGESTION 5 0.0003
711 ADVERSE EVENT 29 0.0003
712 ANGINA PECTORIS 9 0.0003
713 SEPSIS 35 0.0003
714 POST PROCEDURAL COMPLICATION 6 0.0003
715 CARDIAC FAILURE 25 0.0003
716 PLATELET COUNT DECREASED 33 0.0003
717 ATRIAL FIBRILLATION 30 0.0003
718 DIPLOPIA 8 0.0003
719 TREMOR 51 0.0003
720 VISUAL IMPAIRMENT 38 0.0003
721 NODULE 4 0.0003
722 INSOMNIA 81 0.0003
723 HOSPICE CARE 3 0.0003
724 TOOTH INFECTION 4 0.0003
725 DEPRESSION 69 0.0003
726 ABDOMINAL PAIN 70 0.0003
727 CARDIAC FAILURE ACUTE 2 0.0003
728 VOMITING 141 0.0003
729 MALIGNANT MELANOMA 4 0.0003
730 COLITIS ISCHAEMIC 2 0.0003
731 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
732 HEMIPARESIS 5 0.0003
733 TOOTH ABSCESS 3 0.0003
734 HEART RATE INCREASED 29 0.0003
735 INITIAL INSOMNIA 3 0.0003
736 CORONARY ARTERY OCCLUSION 4 0.0003
737 COLITIS 11 0.0003
738 PERITONITIS 6 0.0003
739 NASAL CONGESTION 17 0.0003
740 ABDOMINAL DISTENSION 30 0.0003
741 APHONIA 4 0.0003
742 ENCEPHALOPATHY 7 0.0003
743 NAUSEA 225 0.0003
744 DEVICE OCCLUSION 4 0.0003
745 DUODENAL ULCER 2 0.0003
746 RENAL PAIN 3 0.0003
747 PAIN IN JAW 8 0.0003
748 SWELLING FACE 18 0.0003
749 OSTEOMYELITIS 5 0.0003
750 OESOPHAGITIS 3 0.0003
751 GASTROENTERITIS 4 0.0003
752 ANXIETY 78 0.0003
753 ASPIRATION 3 0.0003
754 DYSPHAGIA 26 0.0003
755 RESTLESSNESS 10 0.0003
756 DIZZINESS 136 0.0003
757 SYNCOPE 27 0.0003
758 THINKING ABNORMAL 5 0.0003
759 DIARRHOEA 173 0.0003
760 EYE INFECTION 3 0.0003
761 HYPOAESTHESIA ORAL 4 0.0003
762 PANCREATITIS 14 0.0003
763 SCAB 3 0.0003
764 NEOPLASM 3 0.0003
765 SHOCK 6 0.0003
766 GASTRIC HAEMORRHAGE 3 0.0003
767 BLOOD CREATININE INCREASED 17 0.0003
768 ACUTE RESPIRATORY FAILURE 5 0.0003
769 FALL 86 0.0003
770 CONCUSSION 2 0.0003
771 WEIGHT DECREASED 72 0.0003
772 RENAL DISORDER 12 0.0003
773 SPINAL PAIN 3 0.0003
774 INFLUENZA LIKE ILLNESS 21 0.0003
775 KIDNEY INFECTION 5 0.0003
776 PRODUCT PRESCRIBING ERROR 6 0.0003
777 CHOLECYSTITIS 3 0.0003
778 MACULAR DEGENERATION 3 0.0003
779 MYELOSUPPRESSION 9 0.0002
780 HIP FRACTURE 8 0.0002
781 ADRENAL INSUFFICIENCY 3 0.0002
782 CEREBRAL INFARCTION 6 0.0002
783 ACUTE CORONARY SYNDROME 2 0.0002
784 DEATH 208 0.0002
785 DYSPHONIA 14 0.0002
786 DERMATITIS ALLERGIC 3 0.0002
787 PRODUCT QUALITY ISSUE 32 0.0002
788 HYPOPHAGIA 6 0.0002
789 HAEMATURIA 8 0.0002
790 UNRESPONSIVE TO STIMULI 6 0.0002
791 HAEMATOMA 6 0.0002
792 CORONARY ARTERY DISEASE 7 0.0002
793 RESPIRATORY TRACT INFECTION 6 0.0002
794 PLEURAL EFFUSION 14 0.0002
795 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
796 ORAL CANDIDIASIS 3 0.0002
797 CARDIOTOXICITY 2 0.0002
798 ISCHAEMIC STROKE 4 0.0002
799 SWOLLEN TONGUE 7 0.0002
800 GOUT 4 0.0002
801 HEART RATE IRREGULAR 5 0.0002
802 HYPERGLYCAEMIA 8 0.0002
803 GAIT DISTURBANCE 42 0.0002
804 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
805 HYPERHIDROSIS 28 0.0002
806 THERAPEUTIC RESPONSE DECREASED 13 0.0002
807 BACTERIAL INFECTION 4 0.0002
808 BLOOD TEST ABNORMAL 3 0.0002
809 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
810 HYPOCALCAEMIA 4 0.0002
811 EXPIRED PRODUCT ADMINISTERED 7 0.0002
812 NERVOUSNESS 11 0.0002
813 VIRAL INFECTION 7 0.0002
814 FEELING JITTERY 4 0.0002
815 SUBDURAL HAEMATOMA 3 0.0002
816 PRODUCT SUBSTITUTION ISSUE 12 0.0002
817 EYE PRURITUS 7 0.0002
818 PARAESTHESIA ORAL 3 0.0002
819 MYELODYSPLASTIC SYNDROME 3 0.0002
820 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
821 PSORIASIS 27 0.0002
822 PLASMA CELL MYELOMA 8 0.0002
823 ORAL HERPES 4 0.0002
824 ACUTE MYOCARDIAL INFARCTION 6 0.0002
825 BODY TEMPERATURE DECREASED 2 0.0002
826 RASH PRURITIC 11 0.0002
827 URINARY INCONTINENCE 6 0.0002
828 HAEMORRHAGE INTRACRANIAL 3 0.0002
829 PRODUCT DOSE OMISSION ISSUE 59 0.0002
830 HOT FLUSH 15 0.0002
831 LACRIMATION INCREASED 6 0.0002
832 BACK PAIN 46 0.0002
833 ABDOMINAL PAIN LOWER 5 0.0002
834 OSTEOPENIA 3 0.0002
835 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
836 FEEDING DISORDER 4 0.0002
837 BLINDNESS 8 0.0002
838 PRODUCT PREPARATION ERROR 4 0.0002
839 MUSCULOSKELETAL CHEST PAIN 3 0.0002
840 NEUROPATHY PERIPHERAL 18 0.0002
841 ABSCESS 3 0.0002
842 RETCHING 4 0.0002
843 JOINT INJURY 4 0.0002
844 EPISTAXIS 14 0.0002
845 BODY HEIGHT DECREASED 2 0.0002
846 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
847 RESPIRATORY DISTRESS 5 0.0002
848 ANGIOEDEMA 8 0.0002
849 HEPATOTOXICITY 4 0.0002
850 PULMONARY OEDEMA 8 0.0002
851 RASH PAPULAR 4 0.0002
852 RESPIRATORY FAILURE 13 0.0002
853 CANDIDA INFECTION 3 0.0002
854 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
855 DRUG INEFFECTIVE 232 0.0002
856 DYSSTASIA 5 0.0002
857 BURNING SENSATION 12 0.0002
858 HYPERKALAEMIA 6 0.0002
859 DEPRESSED MOOD 9 0.0002
860 HEAD DISCOMFORT 3 0.0002
861 LABORATORY TEST ABNORMAL 5 0.0002
862 OCULAR HYPERAEMIA 8 0.0002
863 ATAXIA 2 0.0002
864 HEPATIC FAILURE 5 0.0002
865 APHASIA 5 0.0002
866 TREATMENT NONCOMPLIANCE 9 0.0002
867 VERTIGO 10 0.0002
868 CYTOPENIA 2 0.0002
869 THROMBOSIS 13 0.0002
870 FEMUR FRACTURE 5 0.0002
871 HEPATIC STEATOSIS 3 0.0002
872 HYPONATRAEMIA 9 0.0002
873 DEHYDRATION 21 0.0002
874 CONSTIPATION 34 0.0002
875 MOVEMENT DISORDER 5 0.0002
876 EXPOSURE VIA SKIN CONTACT 4 0.0002
877 CHOKING 3 0.0002
878 BEDRIDDEN 2 0.0002
879 HYPOKALAEMIA 7 0.0002
880 UPPER LIMB FRACTURE 3 0.0002
881 LIP SWELLING 5 0.0001
882 COGNITIVE DISORDER 7 0.0001
883 CARDIAC FAILURE CONGESTIVE 12 0.0001
884 LOSS OF CONSCIOUSNESS 19 0.0001
885 RASH ERYTHEMATOUS 7 0.0001
886 CHRONIC KIDNEY DISEASE 11 0.0001
887 PULMONARY HYPERTENSION 3 0.0001
888 INFLUENZA 16 0.0001
889 HAEMOPTYSIS 4 0.0001
890 DEMENTIA 4 0.0001
891 RASH MACULAR 5 0.0001
892 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
893 EYE PAIN 8 0.0001
894 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
895 EATING DISORDER 3 0.0001
896 IMPAIRED WORK ABILITY 3 0.0001
897 INCORRECT DOSE ADMINISTERED 32 0.0001
898 FLUID RETENTION 7 0.0001
899 PALPITATIONS 16 0.0001
900 BONE PAIN 8 0.0001
901 MYALGIA 23 0.0001
902 NEOPLASM MALIGNANT 9 0.0001
903 EYE SWELLING 5 0.0001
904 COLON CANCER 2 0.0001
905 FEELING ABNORMAL 32 0.0001
906 DEVICE RELATED INFECTION 2 0.0001
907 PERICARDIAL EFFUSION 3 0.0001
908 BALANCE DISORDER 11 0.0001
909 HAEMATOCHEZIA 7 0.0001
910 METABOLIC ACIDOSIS 4 0.0001
911 ABORTION SPONTANEOUS 5 0.0001
912 NEURALGIA 3 0.0001
913 LETHARGY 7 0.0001
914 NO ADVERSE EVENT 22 0.0001
915 OSTEONECROSIS OF JAW 3 0.0001
916 RENAL FAILURE 16 0.0001
917 VISUAL ACUITY REDUCED 4 0.0001
918 AGEUSIA 3 0.0001
919 POLLAKIURIA 5 0.0001
920 DIABETES MELLITUS 9 0.0001
921 DEVICE DISLOCATION 5 0.0001
922 ECZEMA 6 0.0001
923 GASTRITIS 3 0.0001
924 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
925 BLOOD GLUCOSE INCREASED 21 0.0001
926 SKIN DISCOLOURATION 5 0.0001
927 ARRHYTHMIA 5 0.0001
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
929 SEIZURE 12 0.0001
930 ASCITES 3 0.0001
931 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
932 BLOOD POTASSIUM DECREASED 3 0.0001
933 PREMATURE BABY 3 0.0001
934 SOMNOLENCE 20 0.0001
935 CARDIAC DISORDER 9 0.0001
936 NERVOUS SYSTEM DISORDER 3 0.0001
937 DERMATITIS 2 0.0001
938 AGITATION 7 0.0001
939 HYPOACUSIS 4 0.0001
940 CHOLELITHIASIS 3 0.0001
941 STAPHYLOCOCCAL INFECTION 3 0.0001
942 FUNGAL INFECTION 3 0.0001
943 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
944 VISION BLURRED 12 0.0001
945 TINNITUS 4 0.0001
946 NEOPLASM PROGRESSION 3 0.0001
947 HYPOGLYCAEMIA 4 0.0001
948 PANIC ATTACK 3 0.0001
949 DYSURIA 3 0.0001
950 DYSARTHRIA 3 0.0001
951 CARDIOVASCULAR DISORDER 2 0.0001
952 CEREBROVASCULAR ACCIDENT 13 0.0001
953 SPEECH DISORDER 4 0.0001
954 BREAST CANCER FEMALE 2 0.0001
955 CARDIO-RESPIRATORY ARREST 3 0.0001
956 TOXICITY TO VARIOUS AGENTS 12 0.0001
957 MENTAL DISORDER 3 0.0001
958 MYOCARDIAL INFARCTION 12 0.0001
959 INJECTION SITE BRUISING 5 0.0001
960 INJECTION SITE HAEMORRHAGE 5 0.0001
961 INTENTIONAL OVERDOSE 4 0.0001
962 CARDIAC ARREST 5 0.0001
963 DRY EYE 3 0.0001
964 HAEMOGLOBIN DECREASED 6 0.0001
965 PRODUCT STORAGE ERROR 5 0.0001
966 DEVICE MALFUNCTION 4 0.0001
967 SKIN BURNING SENSATION 4 0.0001
968 ACCIDENTAL OVERDOSE 2 0.0001
969 SUICIDAL IDEATION 5 0.0001
970 DYSGEUSIA 4 0.0001
971 INJECTION SITE PAIN 16 0.0001
972 RENAL IMPAIRMENT 4 0.0000
973 DRUG INTERACTION 7 0.0000
974 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
975 BREAST CANCER 4 0.0000
976 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
977 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
978 DISTURBANCE IN ATTENTION 2 0.0000
979 COMPLETED SUICIDE 3 0.0000
980 SKIN EXFOLIATION 3 0.0000
981 INTENTIONAL PRODUCT MISUSE 3 0.0000
982 BLADDER CANCER 2 0.0000
983 INJECTION SITE ERYTHEMA 4 0.0000
984 HAEMORRHAGE 3 0.0000
985 DRY SKIN 2 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000